Sinovac Biotech Ltd (NASDAQ:SVA)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues67.4M72.4M174.3M229.7M
 
 
 
 
 
Cost of Goods Sold12.2M17.3M15.6M19.8M
 
 
 
 
 
Depreciation And Amortization6.2M5.1M4.6M4.9M
 
 
 
 
 
 
Operating ExpensesGross Income49.0M50.0M154.1M204.9M
 
 
 
 
 
General Expenses46.9M56.0M108.8M160.3M
 
 
 
 
 
Research And Development9.5M12.6M20.5M21.9M
 
 
 
 
 
Total Operating Expenses65.3M78.4M129.0M185.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.1M-6.0M45.3M44.6M
 
 
 
 
 
Interest Expense On Debt1.9M1.7M1.6M1.1M
 
 
 
 
 
Other Expenses1.7M6.6M112.0K1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.0M-394.0K45.0M46.6M
 
 
 
 
 
Income Taxes-2.5M-2.7M-8.3M-10.5M
 
 
 
 
 
Minority Interest-861.0K-124.0K-10.9M-14.3M
 
 
 
 
 
Discontinued Operations-728.0K-123.0K0.000.00
 
 
 
Extraordinary Items0.002.5M0.000.00
 
 
Net Income-1.1M-3.1M25.8M21.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.3M56.9M57.0M64.7M
 
 
 
 
 
Shares To Calculate EPS Diluted56.3M56.9M57.1M65.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.01$0.45$0.34
 
 
 
 
 
EPS Diluted-$0.02-$0.05$0.45$0.34